NCT03071406 2026-03-11Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell CarcinomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Active not recruiting50 enrolled 12 charts